Historical record - last NADAC effective date: 8/17/2016
Product Information
SIMVASTATIN 5 MG TABLET is a generic product labeled by Micro Labs Limited, priced at $0.0558 per EA under NDC 42571000590. Its NADAC has been published 129 times since Mar 19, 2014.
FDA first approved this application on Sep 16, 2011.
Strength
5 mg/1
Manufacturer
Micro Labs LimitedNDC
42571000590
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/17/2016
Active Ingredients
SIMVASTATINApproval Type
Generic (ANDA)
FDA Application
ANDA090383FDA Approved
9/16/2011
On Market Since
6/13/2013
Pharmacological Classes
Price Statistics
The NADAC for SIMVASTATIN 5 MG TABLET has been published 129 times since Mar 19, 2014, and over the history we have for it it has risen 19.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0558 per EA |
|---|---|
| All-time high | $0.0558 (Aug 31, 2016) |
| All-time low | $0.0420 (May 18, 2016) |
| Median price | $0.0447 |
| Average price | $0.0455 |
| Largest weekly change | +22.6% (Jun 22, 2016) |
| Weeks tracked | 129 |
| Tracking since | Mar 19, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+19.3%
Last surveyed Aug 31, 2016 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 48% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Micro Labs Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Simvastatin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
HMG-CoA Reductase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SIMVASTATIN 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SIMVASTATIN 5 MG TABLET, manufactured by Micro Labs Limited, is $0.0558 per EA (NDC 42571000590), effective Aug 31, 2016.
How has the price of SIMVASTATIN 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for SIMVASTATIN 5 MG TABLET has risen 19.3%. It has been tracked across 129 weekly CMS publications since Mar 19, 2014.
What are the highest and lowest recorded NADAC prices for SIMVASTATIN 5 MG TABLET?
Since Mar 19, 2014, the NADAC for SIMVASTATIN 5 MG TABLET has ranged from a low of $0.0420 (May 18, 2016) to a high of $0.0558 (Aug 31, 2016), with a median of $0.0447 per EA.
Are there cheaper alternatives to SIMVASTATIN 5 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SIMVASTATIN 5 MG TABLET, is $0.0288 per EA — about 48% below SIMVASTATIN 5 MG TABLET.
Who manufactures SIMVASTATIN 5 MG TABLET?
SIMVASTATIN 5 MG TABLET (NDC 42571000590) is labeled by Micro Labs Limited, and CMS classifies it as a generic product.